On this page
A later event can have several conditions
Section 2.3.2 of the August 2026 BioXcel/OnkosXcel–Teva agreement links specified later payments to regulatory milestones and related timing/conditions. It does not show achievement or payment, and its pharmaceutical bankruptcy context is not a standard SMB earn-out.
Keep the potential amount visible without calling it due
Original fictional exercise, all amounts in U.S. dollars: a different purchase requires US$800,000 at closing and another US$100,000 only if a specified customer renewal occurs by 30 June and the hypothetical contract’s remaining requirements are met. Assume neither a probability nor a current right to that extra payment.
| Payment scenario | Closing amount | Potential later amount | Teaching total |
|---|---|---|---|
| Condition not met | $800,000 | $0 | $800,000 under these assumptions |
| Condition and other requirements met | $800,000 | $100,000 | $900,000 before other deal costs |
| Status unresolved | $800,000 | Unknown | $100,000 is a scenario, not an achieved obligation |
Define what counts as achieved
For the fictional renewal, a sales forecast, unsigned draft and executed qualifying renewal are different evidence. Establish the contract’s actual event definition, required period, adjustments, information access and any dispute process. A later payment may also depend on more than the headline event.
Maintain both the supported base commitment and dated contingent-payment scenarios. Do not add all mutually exclusive milestone alternatives together or treat a maximum advertised price as the buyer’s inevitable outflow.
Use Cash runway for the wider monthly operating position while keeping the separate uneven purchase-payment scenarios and dates in the acquisition model. The recurring tool does not decide whether a milestone was achieved or price became payable.
Scope
- Historical contingent-consideration mechanism and original fictional customer-renewal condition only. No actual milestone, regulatory approval, customer renewal, probability, valuation or payment obligation is determined.
- The actual contract controls event definitions, timing, deductions, caps, alternatives and dispute processes; no generic earn-out terms are supplied.
Next step
Use Cash runway for the wider operating position; retain the event/evidence/notice/invoice/payment chain and one-off contingent scenarios in a separate dated acquisition model.
Terms used here
- Contingent consideration
- Part of a transaction’s price payable only if the specified conditions are met.
- Milestone
- The defined event or performance point that can trigger a contractual consequence, rather than a management forecast.
Sources & review notes
BioXcel Therapeutics; SEC-filed Exhibit 2.1
Passage, dates and research notes
company-filed-agreement · Preamble; section2.3.2(a)–(d) and relevant contingent-event definitions, including alternative development milestones, closing prerequisite, notice/invoice/timing and potential deductions; no event achievement inferred
Historical named deal only; clauses and original fictional owner worksheet do not establish actual completion, enforcement, payment or ordinary-market terms. Historical contingent-consideration mechanism and original fictional customer-renewal condition only. No actual milestone, regulatory approval, customer renewal, probability, valuation or payment obligation is determined.
Bookmark this guide or mark it as read.
Progress privacy
Saving is off by default. Without it, progress lasts only on this page. If you turn it on, this browser profile stores public content IDs and the progress you record. Anyone sharing the profile could see them. No plan inputs or contact details are included. Reset or export in learning settings.
This is a reading aid, not evidence of disclosure delivery, expertise or legal approval.